MedPath

NATESTO

NATESTO

Approved
DIN Number

02450550

Drug Class

Human

Market Date

May 6, 2016

Company
HC

Acerus BioPharma Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02450550
AIG Number0106405007
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA IV)
A
ATC Code
G03BA03 TESTOSTERONE
Product Specifications
Dosage FormGel
Route of AdministrationNasal
AHFS Classification68:08.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

TESTOSTERONEActive
Strength: 4.5 % / W/W
Monograph: TESTOSTERONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.